Concepedia

Candy Rivas

CR

6

Publications

196

Citations

6

H-Index

2013

Active since

Affiliations

University of Arizona(Current)

University of California, Riverside

The University of Texas at Dallas

Department of Physiological Sciences

Arizona Science Center

Candy Rivas is an author at University of Arizona specializing in medicine, cancer research, and systems biology.

Top concepts

Publications per year

2013–2022

6

Publications

6

The HSP90 Inhibitor Ganetespib Synergizes with the MET Kinase Inhibitor Crizotinib in both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models

Naoto Miyajima, Shinji Tsutsumi, Carole Sourbier et al. · Cancer Research · 2013 · 65 citations · Full text

, , +13

Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants

Thomas L. Prince, Toshiki Kijima, Manabu Tatokoro et al. · PLoS ONE · 2015 · 58 citations · Full text

, , +23

The novel <scp>PAR</scp>2 ligand <scp>C</scp>391 blocks multiple <scp>PAR</scp>2 signalling pathways <i>in vitro</i> and <i>in vivo</i>

Scott Boitano, Justin Hoffman, Andrea N. Flynn et al. · British Journal of Pharmacology · 2015 · 37 citations · Full text

Alternaria alternata-induced airway epithelial signaling and inflammatory responses via protease-activated receptor-2 expression

Candy Rivas, Hillary Schiff, Aubin Moutal et al. · Biochemical and Biophysical Research Communications · 2021 · 15 citations · Full text

, , +12

β‐Arrestin‐biased proteinase‐activated receptor‐2 antagonist C781 limits allergen‐induced airway hyperresponsiveness and inflammation

Hillary Schiff, Candy Rivas, William Pederson et al. · British Journal of Pharmacology · 2022 · 11 citations · Full text

Rows per page

1–5 of 6